CN1301727C - Externally applied Chinese medicine preparation for treating skin disease and its preparation method - Google Patents
Externally applied Chinese medicine preparation for treating skin disease and its preparation method Download PDFInfo
- Publication number
- CN1301727C CN1301727C CNB2005100433367A CN200510043336A CN1301727C CN 1301727 C CN1301727 C CN 1301727C CN B2005100433367 A CNB2005100433367 A CN B2005100433367A CN 200510043336 A CN200510043336 A CN 200510043336A CN 1301727 C CN1301727 C CN 1301727C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- radix
- preparation
- medicine preparation
- rhizoma rhei
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to an external traditional Chinese medicine preparation for treating dermatosis and a preparation method thereof. The traditional Chinese medicine preparation is prepared from the raw materials with the following weight compounding ratio: 20 to 150g of eleusine indica, 1 to 12g of asarum, 20 to 150g of rhubarb, 20 to 150g of goldenlarch bark and 2 to 20g of borneol. The medicine is a pure traditional Chinese medicine preparation, has no toxic or side effect on patients, and has the advantages of convenient use and low cost of using the medicine. The traditional Chinese medicine preparation has obvious effect and short treating course on treating itch of skin, eczema, dermatitis, etc., and especially, the itching alleviating effect is rapid and obvious. The allergy and the medicine resistance can not occur, and the traditional Chinese medicine preparation has obvious curative effect on tinea corporis, tinea manuum and tinea pedis.
Description
Technical field
The invention belongs to technical field of Chinese medicines, particularly relate to the dermopathic Chinese medicine for outer use of a kind of treatment.
Background technology
In clinical common skin disease, eczema and dermatitis class occupy very most of, and their common feature is very to itch unbearably and be difficult to cure.At present, the Chinese medicine preparation that is used for the treatment of alopecia is existing multiple, as Piyanping ointment, compound recipe fluocinonide ointment etc., they mostly are Western medicine or chemicals, all have the deficiency slow, weak curative effect of growing the course of treatment, take effect, particularly can not within a short period of time antipruritic as early as possible, and easily recurrence is easy to generate Drug resistance after the drug withdrawal, and life-time service can have side effects to human body.Therefore, the advantage of punishment performance China tradition Chinese medicine, it is very necessary to seek a kind of effective Chinese medicine for outer use of dermatosiss such as eczema and dermatitis for the treatment of.
Summary of the invention
Purpose of the present invention is exactly that a kind of Chinese medicine for outer use that can effectively treat the various skin disease will be provided.
Another object of the present invention provides a kind of preparation method for the treatment of dermopathic Chinese medicine for outer use.
Making Chinese medicine preparation raw materials of effective components composition of the present invention and weight proportion thereof is: Radix Rumicis Crispi 20-150g, Herba Asari 1-12g, Radix Et Rhizoma Rhei 20-150g, Cortex Pseudolaricis 20-150g, Borneolum Syntheticum 2-20g.
The weight proportion of making the preferred prescription raw material of Chinese medicine preparation effective ingredient of the present invention is: Radix Rumicis Crispi 70-100g, Herba Asari 5-8g, Radix Et Rhizoma Rhei 70-100g, Cortex Pseudolaricis 70-100g, Borneolum Syntheticum 8-12g.
The weight proportion of making the best prescription raw material of Chinese medicine preparation effective ingredient of the present invention is: Radix Rumicis Crispi 80g, Herba Asari 6g, Radix Et Rhizoma Rhei 80g, Cortex Pseudolaricis 80g, Borneolum Syntheticum 10g.
The preparation method of Chinese medicine preparation of the present invention is: get Radix Rumicis Crispi, Herba Asari, Radix Et Rhizoma Rhei, Cortex Pseudolaricis by weight ratio and be ground into 120 order fine powders, alcoholic solution with 70% extracts twice, extracting liquid filtering is standby, with twice of said medicine residue reuse water extraction, extracting liquid filtering is standby, Borneolum Syntheticum is dissolved in an amount of alcoholic solution, above-mentioned three kinds of solution are mixed, add sorbitol 5 grams, add water to 1000ml then, transfer the ph value to 6-8 with sodium bicarbonate or hydrochloric acid solution, be the finished product externally applied liniment behind the sterilization filling.
Medicine of the present invention is a pure Chinese medicinal preparation, without any side effects to the patient, easy to use, drug cost is low, to dermatosis instant effect, short treating periods such as treatment skin pruritus, eczema and dermatitis classes, particularly antipruritic effect is obvious rapidly, allergy and Drug resistance can not occur, and tinea corporis and tinea manus and pedis are also had better curative effect.Medicine of the present invention is through carrying out clinical observation to 200 different skin patients, and total effective rate can reach 97%.
The specific embodiment
Embodiment 1:
Treat dermopathic Chinese medicine for outer use, raw material composition and the weight proportion thereof of making this pharmaceutically active ingredient are: Radix Rumicis Crispi 30g, Herba Asari 2g, Radix Et Rhizoma Rhei 100g, Cortex Pseudolaricis 80g, Borneolum Syntheticum 5g.
Embodiment 2:
Treat dermopathic Chinese medicine for outer use, raw material composition and the weight proportion thereof of making this pharmaceutically active ingredient are: Radix Rumicis Crispi 100g, Herba Asari 8g, Radix Et Rhizoma Rhei 70g, Cortex Pseudolaricis 90g, Borneolum Syntheticum 8g.
Embodiment 3:
Treat the preparation method of dermopathic Chinese medicine for outer use, get Radix Rumicis Crispi 80g, Herba Asari 6g, Radix Et Rhizoma Rhei 80g, Cortex Pseudolaricis 80g are ground into 120 order fine powders, the alcoholic solution with 70% extracts twice, and extracting liquid filtering is standby; With said medicine residue reuse water extraction twice, extracting liquid filtering is standby; Borneolum Syntheticum 10g is dissolved in the 50ml70% alcoholic solution, above-mentioned three kinds of solution are mixed, add sorbitol 5g, add water to 1000ml then, transfer the ph value to 6-8 with sodium bicarbonate or hydrochloric acid solution, sterilization filling is finished product externally applied liniment medicinal liquid.
Claims (4)
1, the dermopathic Chinese medicine for outer use of a kind of treatment is characterized in that raw material composition and the weight proportion thereof of making this pharmaceutically active ingredient are: Radix Rumicis Crispi 20-150g, Herba Asari 1-12g, Radix Et Rhizoma Rhei 20-150g, Cortex Pseudolaricis 20-150g, Borneolum Syntheticum 2-20g.
2, treat dermopathic Chinese medicine for outer use according to claim 1, it is characterized in that raw material composition and the weight proportion thereof of making this pharmaceutically active ingredient are: Radix Rumicis Crispi 70-100g, Herba Asari 5-8g, Radix Et Rhizoma Rhei 70-100g, last chaste tree skin 70-100g, Borneolum Syntheticum 8-12g.
3, as the dermopathic Chinese medicine for outer use of treatment as described in the claim 2, the raw material that it is characterized in that making this pharmaceutically active ingredient forms and weight proportion is: Radix Rumicis Crispi 80g, Herba Asari 6g, Radix Et Rhizoma Rhei 80g, Cortex Pseudolaricis 80g, Borneolum Syntheticum 10g.
4, a kind of preparation method as the dermopathic Chinese medicine for outer use of treatment as described in the claim 3, it is characterized in that getting by weight ratio Radix Rumicis Crispi, Herba Asari, Radix Et Rhizoma Rhei, Cortex Pseudolaricis and be ground into 120 order fine powders, alcoholic solution with 70% extracts twice, extracting liquid filtering is standby, with twice of said medicine residue reuse water extraction, extracting liquid filtering is standby, Borneolum Syntheticum is dissolved in an amount of alcoholic solution, above-mentioned three kinds of solution are mixed, add sorbitol 5 grams, add water to 1000ml then, transfer the ph value to 6-8 with sodium bicarbonate or hydrochloric acid solution, sterilization filling is the finished product medicinal liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100433367A CN1301727C (en) | 2005-04-16 | 2005-04-16 | Externally applied Chinese medicine preparation for treating skin disease and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100433367A CN1301727C (en) | 2005-04-16 | 2005-04-16 | Externally applied Chinese medicine preparation for treating skin disease and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1698739A CN1698739A (en) | 2005-11-23 |
| CN1301727C true CN1301727C (en) | 2007-02-28 |
Family
ID=35475092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100433367A Expired - Fee Related CN1301727C (en) | 2005-04-16 | 2005-04-16 | Externally applied Chinese medicine preparation for treating skin disease and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1301727C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115400172B (en) * | 2022-10-28 | 2023-09-15 | 辽宁中医药大学附属医院 | A Chinese medicinal composition for treating insect bite, and its preparation method |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1110170A (en) * | 1994-09-30 | 1995-10-18 | 贵州高科药业公司 | Shangfuling spray-filming agent for curing wound and skin disease |
| CN1273111A (en) * | 2000-03-30 | 2000-11-15 | 朱江 | Ointment for treating skin tinea |
| CN1390591A (en) * | 2002-07-18 | 2003-01-15 | 代元丁 | Chinese-medicinal liniment fr treating dermatopathy |
-
2005
- 2005-04-16 CN CNB2005100433367A patent/CN1301727C/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1110170A (en) * | 1994-09-30 | 1995-10-18 | 贵州高科药业公司 | Shangfuling spray-filming agent for curing wound and skin disease |
| CN1273111A (en) * | 2000-03-30 | 2000-11-15 | 朱江 | Ointment for treating skin tinea |
| CN1390591A (en) * | 2002-07-18 | 2003-01-15 | 代元丁 | Chinese-medicinal liniment fr treating dermatopathy |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1698739A (en) | 2005-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102614440B (en) | Multi-herb antibacterial liquid | |
| CN101199748A (en) | Chinese medicine preparation for treating hematonosis | |
| CN102058673A (en) | Chinese medicine composition for expelling wind and removing dampness and preparation method thereof | |
| CN101474192A (en) | Veramyst medicinal preparation and preparation method | |
| CN1301727C (en) | Externally applied Chinese medicine preparation for treating skin disease and its preparation method | |
| CN102846767A (en) | Preparation process of integration-type novel formulation of MAXINGGANSHI decoction and production method thereof | |
| CN102579528B (en) | Medicine composition for preventing and curing prostatic diseases | |
| CN102283928A (en) | Technology for preparing novel integrated dosage form of Ermiao powder and production method thereof | |
| CN108434227A (en) | A kind of drug for treating tinea pedis | |
| CN101057922A (en) | Traditional Chinese medicine preparation for treating vitiligo | |
| CN101129805A (en) | External application medicine for treating hypertension | |
| CN103933386B (en) | Compound hemophiliac capsule used for treating hemophilia and preparation method thereof | |
| CN1256134C (en) | Medicinal composition for treating rheumatoid | |
| CN101590206A (en) | Traditional Chinese medicine for treating biliary calculi | |
| CN101474189A (en) | Halometasone medicinal preparation and preparation method | |
| CN105362382A (en) | Traditional Chinese medicine composition for treating recurrent oral ulcer and application thereof | |
| CN1443545A (en) | Medicine for curing acne and its preparation method | |
| CN106880654B (en) | Application of panax japonicus extract in preparing medicine for treating rhinitis and composition | |
| CN102415953B (en) | Deodorizing medicinal cosmetic and preparation method thereof | |
| CN105412731A (en) | Ointment for treating skin pruritus and preparing method thereof | |
| CN1965980A (en) | Quick-acting vagina shrinking agent and method for preparing same | |
| Vikas et al. | An Update on Urolithiatic Plant Drugs as Alternative Treatment Option for Mitigation of Kidney Stones | |
| CN102526647A (en) | Preparation technology and production method of novel dual-purpose decoction integrated dosage form | |
| CN103585330B (en) | A kind of Chinese medicine composition for cutaneous fungal infection and preparation method thereof | |
| CN102846848B (en) | Traditional Chinese medicine preparation for ovarian stimulation and preparation technology thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070228 Termination date: 20120416 |